Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Specified Drug-use Surveillance of Fabhalta Capsules |
Paroxysmal Nocturnal Hemoglobinuria | Japan | NCT06606314 | |
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS |
Relapsing Multiple Sclerosis | Phase3 | United States | NCT03650114 |
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) |
Healthy Volunteers, Pulmonary Arterial Hypertension | Phase1, Phase2 | United States | NCT06649110 |
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). |
Systemic Lupus Erythematosus, SLE | Phase1 | Spain | NCT06335979 |
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) |
Sickle Cell Disease | Phase3 | United States | NCT06439082 |
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) |
Amyotrophic Lateral Sclerosis (ALS) | Phase2 | United States | NCT06643481 |
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) |
Spinal Muscular Atrophy (SMA) | Greece Ireland Israel Korea, Republic of Poland Portugal Romania Russian Federation Taiwan United States View All |
NCT04174157 | |
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy |
Atypical Hemolytic Uremic Syndrome | Phase3 | Austria Brazil China Czechia Greece India Japan Korea, Republic of Slovakia Slovenia Taiwan United Kingdom United States View All |
NCT04889430 |
Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis |
Moderate-to-severe Plaque Psoriasis | Russian Federation | NCT06142357 | |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 | Argentina Austria Belgium Bulgaria Chile China Colombia Croatia Denmark Georgia Guatemala Hong Kong India Ireland Israel Italy Jordan Latvia Lebanon Lithuania Malaysia Mexico Netherlands Poland Saudi Arabia Slovakia Spain Switzerland Taiwan United Arab Emirates United Kingdom United States View All |
NCT05147220 |